| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193488 | Annals of Allergy, Asthma & Immunology | 2007 | 7 Pages |
Abstract
Therapy with ICSs alone or combined with LABAs is effective for the treatment of asthma; however, current prescribing patterns may not optimize the potential of these therapies. A reexamination of treatment regimens and goals for asthma therapy is necessary to improve outcomes for patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Gene L. MD,